Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Wendler

Showing results (41-50 of 214) with videos related to

Pageof 22
Sort By:
Kennedy Institute of Ethics Journal|June 24, 2011
A framework for risk-benefit evaluations in biomedical researchAnnette Rid, David Wendler
Clinical Trials (London, England)|January 27, 2026
Commentary: Multi-stage consent for time-sensitive clinical trialsDaniel Karel, David Wendler
The American Journal of Bioethics : AJOB|April 16, 2014
Which alternatives should investigators disclose to research subjects?John Phillips, David Wendler
The Journal of Medicine and Philosophy|February 15, 2014
Use of a patient preference predictor to help make medical decisions for incapacitated patientsAnnette Rid, David Wendler
Archives of Pediatrics & Adolescent Medicine|January 9, 2008
Children's and their parents' views on facing research risks for the benefit of othersDavid Wendler, Tammara Jenkins
Vaccine|February 27, 2025
Assessing the risks of current COVID-19 challenge trials systematicallyNir Eyal, David Wendler
The Journal of Pediatrics|December 2, 2006
Minimal risk in pediatric researchDavid Wendler, Sumeeta Varma
Internal Medicine Journal|December 23, 2020
Ethics of information-gathering interventions in innovative practiceJake Earl, David Wendler
Cambridge Quarterly of Healthcare Ethics : CQ : the International Journal of Healthcare Ethics Committees|September 15, 2015
Is there a role for assent or dissent in animal research?Holly Kantin, David Wendler
Kennedy Institute of Ethics Journal|February 23, 2011
Does it matter whether investigators intend to benefit research subjects?David Wendler, Emily Abdoler
Pageof 22

Showing results (41-50 of 214) with videos related to

Sort By:
Pageof 22
Kennedy Institute of Ethics Journal|June 24, 2011
A framework for risk-benefit evaluations in biomedical researchAnnette Rid, David Wendler
Clinical Trials (London, England)|January 27, 2026
Commentary: Multi-stage consent for time-sensitive clinical trialsDaniel Karel, David Wendler
The American Journal of Bioethics : AJOB|April 16, 2014
Which alternatives should investigators disclose to research subjects?John Phillips, David Wendler
The Journal of Medicine and Philosophy|February 15, 2014
Use of a patient preference predictor to help make medical decisions for incapacitated patientsAnnette Rid, David Wendler
Archives of Pediatrics & Adolescent Medicine|January 9, 2008
Children's and their parents' views on facing research risks for the benefit of othersDavid Wendler, Tammara Jenkins
Vaccine|February 27, 2025
Assessing the risks of current COVID-19 challenge trials systematicallyNir Eyal, David Wendler
The Journal of Pediatrics|December 2, 2006
Minimal risk in pediatric researchDavid Wendler, Sumeeta Varma
Internal Medicine Journal|December 23, 2020
Ethics of information-gathering interventions in innovative practiceJake Earl, David Wendler
Cambridge Quarterly of Healthcare Ethics : CQ : the International Journal of Healthcare Ethics Committees|September 15, 2015
Is there a role for assent or dissent in animal research?Holly Kantin, David Wendler
Kennedy Institute of Ethics Journal|February 23, 2011
Does it matter whether investigators intend to benefit research subjects?David Wendler, Emily Abdoler
Pageof 22